SCHEMBL31424405

SCHEMBL31424405

Cc1cc(-n2nc3c(c2Br)[C@H](C)N(C(=O)OC(C)(C)C)CC3)cc(C)c1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.33
▸ USP30 Q70CQ3 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ C5AR1 P21730 3/20 0.31
▸ NR1H2 P55055 1/20 0.31
▸ NR1H3 Q13133 1/20 0.31
▸ GLP1R P43220 3/20 0.31
▸ SUV39H2 Q9H5I1 2/20 0.31
▸ HPGDS O60760 2/20 0.31
▸ TP53 P04637 2/20 0.31
▸ UCHL1 P09936 2/20 0.31
▸ MAPT P10636 1/20 0.31
▸ ACACB O00763 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ GLA P06280 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28952435 0.88 NR1H2 (0.33) THRBLMNANPSR1C5AR1NR1H2
SCHEMBL20014821 0.88 NR1H2 (0.33) THRBLMNANPSR1C5AR1NR1H2
SCHEMBL31692337 0.88 THRB (0.33) THRBLMNANPSR1C5AR1NR1H2
SCHEMBL31692240 0.87 THRB (0.33) THRBLMNANPSR1C5AR1NR1H2
SCHEMBL38651835 0.86 F12 (0.32) THRBUSP30C5AR1NR1H2UCHL1
SCHEMBL31692242 0.86 THRB (0.32) THRBLMNANPSR1C5AR1NR1H2
SCHEMBL31692219 0.86 THRB (0.34) THRBUSP30LMNANPSR1C5AR1
SCHEMBL31692410 0.85 NR1H2 (0.32) THRBUSP30C5AR1NR1H2NR1H3
SCHEMBL31692524 0.85 THRB (0.32) THRBC5AR1NR1H2NR1H3GLP1R
SCHEMBL31692614 0.84 GLP1R (0.32) THRBLMNANPSR1NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304572-A1 HETEROCYCLIC GLP-1R AGONISTS BIOMEA FUSION, INC. 2025-10-02 — — US disclosed
CN-119431365-A Phenyl heterocyclic derivative-containing regulator and preparation method and application thereof 江苏豪森药业集团有限公司 2025-02-14 — — CN disclosed
WO-2025026270-A1 BENZO NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2025-02-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304572-A1 HETEROCYCLIC GLP-1R AGONISTS GLP1R, GPR119, GIPR THRB 185/4885USP30 3530/4885LMNA 3557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback